CD4 and melanoma: Moreover, memory env-reactive CD4+ T cells, generated by B3-Ab:env123–139 immunization, were highly effective in rejecting B16-Ab:env123–139 melanoma cells, indicating that Ab:env123–139 complexes expressed in B16 cells can be recognized effectively.